Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Fatigue in multiple sclerosis: a look at the role of poor sleep.
Dual role of microglia in health and disease: pushing the balance toward repair.
Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain.
A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.
[Vitamin d, determinant of bone and extrabone health . Import ance of vitamin d supplementation in milk and dairy products].
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis.
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
Teriflunomide in relapsing multiple sclerosis: therapeutic utility.
Immunoadsorption in steroid-refractory multiple sclerosis.
Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium.
Marijuana Legalization: Impact on Physicians and Public Health.
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
PAMP-DAMPs interactions mediates development and progression of multiple sclerosis.
Invisible Killers.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.
Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis.
Cell surface levels of endothelial ICAM-1 influence thetranscellular or paracellularT-celldiapedesis across the blood-brain barrier.
Effects of a Tailored Positive Psychology Intervention on Well-being and Pain in Individuals with Chronic Pain and a Physical Disability: A Feasibility Trial.
Differential modulation of the juxtaparanodal complex in Multiple Sclerosis.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Pages
« first
‹ previous
…
605
606
607
608
609
610
611
612
613
…
next ›
last »